Jung-Kyun Kim
Private Equity Investor bei Nau IB Capital Co. Ltd. (Venture Capital)
Profil
Jung-Kyun Kim is currently the Managing Director at Nau IB Capital Co. Ltd., a venture capital firm.
Prior to this, he was the Chief Executive Officer at Boryung Holdings Co., Ltd.
Mr. Kim completed his undergraduate degree at Korea Aerospace University.
Aktive Positionen von Jung-Kyun Kim
| Unternehmen | Position | Beginn |
|---|---|---|
Nau IB Capital Co. Ltd. (Venture Capital)
 Nau IB Capital Co. Ltd. (Venture Capital) Investment ManagersFinance Nau IB Capital Co. Ltd. (Venture Capital) (Nau IB) is a venture capital subsidiary of Nau IB Capital founded by Seung-Won Lee in 2003. The firm is headquartered in Seoul, Korea. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Jung-Kyun Kim
| Unternehmen | Position | Ende |
|---|---|---|
Boryung Holdings Co., Ltd.
 Boryung Holdings Co., Ltd. BiotechnologyHealth Technology Boryung Holdings Co., Ltd. engages in the provision of real estate leasing and distributing technologies for remedial medicines. Its products are used in remedies for hyperlipidemia and Tamsulosin for prostatic hypertrophy. The company was founded on May 5, 1990 and is headquartered in Seoul, South Korea. | Vorstandsvorsitzender | - |
Ausbildung von Jung-Kyun Kim
| Korea Aerospace University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Nau IB Capital Co. Ltd. (Venture Capital)
Nau IB Capital Co. Ltd. (Venture Capital) Investment ManagersFinance Nau IB Capital Co. Ltd. (Venture Capital) (Nau IB) is a venture capital subsidiary of Nau IB Capital founded by Seung-Won Lee in 2003. The firm is headquartered in Seoul, Korea. | Finance |
Boryung Holdings Co., Ltd.
Boryung Holdings Co., Ltd. BiotechnologyHealth Technology Boryung Holdings Co., Ltd. engages in the provision of real estate leasing and distributing technologies for remedial medicines. Its products are used in remedies for hyperlipidemia and Tamsulosin for prostatic hypertrophy. The company was founded on May 5, 1990 and is headquartered in Seoul, South Korea. | Health Technology |
